This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

On The Pulse, Reporting Live From Bruce's Corner (Hemp, Inc.): Arizona's Rose Law Group

LAS VEGAS, Feb. 4, 2013 /PRNewswire/ -- In a thriving medical marijuana and industrial hemp industry, innovation abounds and Bruce Perlowin, Hemp, Inc.'s (OTC: HEMP) CEO (the only CEO of 2 companies in the sector he started) and driving force behind the industry has his finger on the pulse. " Bruce's Corner" is Hemp, Inc.'s insightful news stop for material events in the medical marijuana and industrial hemp industry. Known as the "Mike Wallace of the Medical Marijuana and Industrial Hemp Industry," Bruce Perlowin reports today on: Interview with M. Ryan Hurley, Co-Chair of Arizona's Rose Law Group's Medical Marijuana Practice Group .  

(Logo: http://photos.prnewswire.com/prnh/20121107/LA08133LOGO)

The looming deadline for opening Arizona medical marijuana dispensaries is rapidly approaching. So too are certain other dates and milestones that must be met along the way. Mr. Hurley will be guest speaking on a new Webinar for Arizona's MMJ business professionals entitled " Arizona's Looming MMJ Deadlines." Hurley and Arizona's entire Rose Law Group have been committed to the industry from day one and remain the go-to attorneys for all medical marijuana needs in Arizona.  

M. Ryan Hurley said during the interview with Bruce Perlowin, "It's slow and steady progress and a constant battle against some of our elected officials to fully implement the will of the voters."

The Rose Law Group is a founding member of the National Cannabis Industry Association (NCIA).

Perlowin stated, "I applaud the work this law firm is doing in our industry. Their weekly email newsletter is informative and helps me keep my finger on the pulse of material industry events in Arizona."

Stay tuned for more to come as roving reporter, Bruce Perlowin for " Bruce's Corner," the "Mike Wallace of the Medical Marijuana and Industrial Hemp Industries" reports on industry material "news-you-can-use." Don't miss Bruce Perlowin at the industry's next main event, Hempcon 2013 Tour in San Bernardino, California, February 8-10, 2013 at the NOS Events Center (689 South "E" Street). Bruce will be one of the keynote speakers. On Friday, February 8th, he'll be speaking on "Hemp" and on Saturday, February 9th, he'll be speaking on "Stocks and the Hemp Community." This is one of the most anticipated events of 2013. For the last four years, Bruce Perlowin has been a staple at every Hempcon tour and just about every other major industry event. He has spoken at events and has been an exhibitor, interfacing with every aspect of the industrial hemp sector. As a spokesman, he reports on the radio. (See also thestockradio.com.)

Did you miss Bruce Perlowin's last report for Bruce's Corner? Check it out. ( 1/30/2013 -- Hemp, Inc. on the Pulse of the Medical Marijuana and Industrial Hemp Industry).

About Hemp, Inc.

Hemp, Inc. (OTC: HEMP) focuses on the vast market created by the quickly emerging, and growing, multibillion dollar industrial hemp industry. Hemp, Inc. (OTC: HEMP) is not involved in the cultivation or marketing of medical marijuana. It is the company's belief that legalization of hemp in all 50 states and at the federal level will come to pass. With that in mind, the company is building infrastructure with the potential to gain substantial market share before and after industrial hemp prohibition ends. (Pending any federal licensing or other requirements, that may be enacted after hemp prohibition ends).

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,191.37 -195.84 -1.13%
S&P 500 2,002.16 -27.39 -1.35%
NASDAQ 4,637.9940 -43.5030 -0.93%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs